Medifast
MED
158 hedge funds and large institutions have $228M invested in Medifast in 2024 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 50 increasing their positions, 47 reducing their positions, and 65 closing their positions.
6% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 47
9.98% less ownership
Funds ownership: 105.31% → 95.33% (-10%)
15% less funds holding
Funds holding: 186 → 158 (-28)
25% less call options, than puts
Call options by funds: $13.4M | Put options by funds: $17.8M
42% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 65
48% less capital invested
Capital invested by funds: $440M → $228M (-$212M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$8.59M |
| 2 |
D.E. Shaw & Co
New York
|
+$6.56M |
| 3 |
Jane Street
New York
|
+$6.51M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$5.62M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$48.3M |
| 2 |
BlackRock
New York
|
-$24.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$13.6M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$12.6M |
| 5 |
State Street
Boston,
Massachusetts
|
-$5.36M |
MED Hedge Fund Activity: Q2 2024 in Review
158 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q2 2024, worth a combined $228M — down 48% from $440M a quarter earlier.
Sellers outnumbered buyers: 65 funds closed out of MED and 38 opened new positions — a net loss of 27 holders — while 47 trimmed existing stakes and 50 added.
The largest buyer was Acadian Asset Management, adding an estimated $8.59M. The largest seller was Pacer Advisors, exiting entirely with an estimated $48.3M sold.
- 158 institutional investors held Medifast (MED) as of Q2 2024, down from 186 in Q1 2024.
- Funds reported $228M of Medifast stock for Q2 2024, down 48% quarter-over-quarter.
- 38 funds opened new Medifast positions in Q2 2024 and 65 closed out, a net change of -27 holders.
- The largest Medifast buyer in Q2 2024 was Acadian Asset Management, an estimated $8.59M added.
- The largest Medifast seller in Q2 2024 was Pacer Advisors, an estimated $48.3M sold.
Based on aggregated 13F filings for Q2 2024.